BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 14733828)

  • 21. Vigabatrin therapy in patient with succinic semialdehyde dehydrogenase deficiency.
    Gibson KM; DeVivo DC; Jakobs C
    Lancet; 1989 Nov; 2(8671):1105-6. PubMed ID: 2572834
    [No Abstract]   [Full Text] [Related]  

  • 22. Vigabatrin and newer interventions in succinic semialdehyde dehydrogenase deficiency.
    Gropman A
    Ann Neurol; 2003; 54 Suppl 6():S66-72. PubMed ID: 12891656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Succinic semialdehyde dehydrogenase deficiency (SSADH) (4-hydroxybutyric aciduria, gamma-hydroxybutyric aciduria).
    Gordon N
    Eur J Paediatr Neurol; 2004; 8(5):261-5. PubMed ID: 15341910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proton MR spectroscopy in succinic semialdehyde dehydrogenase deficiency.
    Ethofer T; Seeger U; Klose U; Erb M; Kardatzki B; Kraft E; Landwehrmeyer GB; Grodd W; Storch A
    Neurology; 2004 Mar; 62(6):1016-8. PubMed ID: 15037717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unusual enzyme findings in five patients with metabolic profiles suggestive of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria).
    Gibson KM; Sweetman L; Kozich V; Pijackova A; Tscharre A; Cortez A; Eyskens F; Jakobs C; Duran M; Poll-The BT
    J Inherit Metab Dis; 1998 Jun; 21(3):255-61. PubMed ID: 9686370
    [No Abstract]   [Full Text] [Related]  

  • 26. Rapid and sensitive detection of urinary 4-hydroxybutyric acid and its related compounds by gas chromatography-mass spectrometry in a patient with succinic semialdehyde dehydrogenase deficiency.
    Shinka T; Inoue Y; Ohse M; Ito A; Ohfu M; Hirose S; Kuhara T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Aug; 776(1):57-63. PubMed ID: 12127325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [4-Hydroxybutyric aciduria].
    Asai M; Wada Y
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):250-1. PubMed ID: 9590039
    [No Abstract]   [Full Text] [Related]  

  • 28. 4-Hydroxybutyric aciduria: clinical findings and vigabatrin therapy.
    Uziel G; Bardelli P; Pantaleoni C; Rimoldi M; Savoiardo M
    J Inherit Metab Dis; 1993; 16(3):520-2. PubMed ID: 7609441
    [No Abstract]   [Full Text] [Related]  

  • 29. Significant behavioral disturbances in succinic semialdehyde dehydrogenase (SSADH) deficiency (gamma-hydroxybutyric aciduria).
    Gibson KM; Gupta M; Pearl PL; Tuchman M; Vezina LG; Snead OC; Smit LM; Jakobs C
    Biol Psychiatry; 2003 Oct; 54(7):763-8. PubMed ID: 14512218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Succinic semialdehyde dehydrogenase deficiency in children and adults.
    Pearl PL; Novotny EJ; Acosta MT; Jakobs C; Gibson KM
    Ann Neurol; 2003; 54 Suppl 6():S73-80. PubMed ID: 12891657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GABA, gamma-hydroxybutyric acid, and neurological disease.
    Wong CG; Bottiglieri T; Snead OC
    Ann Neurol; 2003; 54 Suppl 6():S3-12. PubMed ID: 12891648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical correlation of dysequilibrium syndrome and 4-hydroxybutyric aciduria.
    Gibson KM; Sweetman L; Nyhan WL; Bowen P
    J Inherit Metab Dis; 1985; 8(2):58. PubMed ID: 3939531
    [No Abstract]   [Full Text] [Related]  

  • 33. Monitoring gamma-hydroxybutyric acid levels in succinate-semialdehyde dehydrogenase deficiency.
    Pearl PL; Gropman A
    Ann Neurol; 2004 Apr; 55(4):599; author reply 599. PubMed ID: 15048909
    [No Abstract]   [Full Text] [Related]  

  • 34. The first case of 4-hydroxybutyric aciduria in Japan.
    Ishiguro Y; Kajita M; Aoshima T; Watanabe K; Kimura M; Yamaguchi S
    Brain Dev; 2001 Mar; 23(2):128-30. PubMed ID: 11248463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Succinic semialdehyde dehydrogenase deficiency: decrease in 4-OH-butyric acid levels with low doses of vigabatrin].
    Escalera GI; Ferrer I; Marina LC; Sala PR; Salomons GS; Jakobs C; Pérez-Cerdá C
    An Pediatr (Barc); 2010 Feb; 72(2):128-32. PubMed ID: 20018576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two exon-skipping mutations as the molecular basis of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria).
    Chambliss KL; Hinson DD; Trettel F; Malaspina P; Novelletto A; Jakobs C; Gibson KM
    Am J Hum Genet; 1998 Aug; 63(2):399-408. PubMed ID: 9683595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel ALDH5A1 mutation in a patient with succinic semialdehyde dehydrogenase deficiency.
    Kwok JS; Yuen CL; Law LK; Tang NL; Cherk SW; Yuen YP
    Pathology; 2012 Apr; 44(3):280-2. PubMed ID: 22437753
    [No Abstract]   [Full Text] [Related]  

  • 38. Selective involvement of the globus pallidus and dentate nucleus in succinic semialdehyde dehydrogenase deficiency.
    Ziyeh S; Berlis A; Korinthenberg R; Spreer J; Schumacher M
    Pediatr Radiol; 2002 Aug; 32(8):598-600. PubMed ID: 12136353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical spectrum of succinic semialdehyde dehydrogenase deficiency.
    Pearl PL; Gibson KM; Acosta MT; Vezina LG; Theodore WH; Rogawski MA; Novotny EJ; Gropman A; Conry JA; Berry GT; Tuchman M
    Neurology; 2003 May; 60(9):1413-7. PubMed ID: 12743223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on analogues of succinic semialdehyde as substrates for succinate semialdehyde dehydrogenase from rat brain.
    Manzocchi A; Biondi P; Secchi C; Santaniello E
    J Neurochem; 1986 Jun; 46(6):1895-8. PubMed ID: 3701337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.